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Abstract
Background—We evaluated mortality among 5,964 former U.S. commercial cockpit crew 
(pilots and flight engineers). The outcomes of a priori interest were non-chronic lymphocytic 
leukemia, central nervous system (CNS) cancer (including brain), and malignant melanoma.
Methods—Vital status was ascertained through 2008. Life table and Cox regression analyses 
were conducted. Cumulative exposure to cosmic radiation was estimated from work history data.
Results—Compared to the U.S. general population, mortality from all causes, all cancer, and 
cardiovascular diseases was decreased, but mortality from aircraft accidents was highly elevated. 
Mortality was elevated for malignant melanoma but not for non-chronic lymphocytic leukemia. 
CNS cancer mortality increased with an increase in cumulative radiation dose.
Conclusions—Cockpit crew had a low all-cause, all-cancer, and cardiovascular disease 
mortality but elevated aircraft accident mortality. Further studies are needed to clarify the risk of 
CNS and other radiation-associated cancers in relation to cosmic radiation and other workplace 
exposures.
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INTRODUCTION
Commercial airline cockpit crew (pilots and flight engineers) are occupationally exposed to 
cosmic ionizing radiation [IARC, 2000]. The cosmic radiation field at aircraft altitudes 
consists mainly of secondary neutrons and gamma radiation, with some protons, alpha 
particles, and heavy nuclei [Friedberg et al., 1989; Oksanen, 1998]. It has been estimated 
that approximately 40–65% of the cosmic radiation exposure of cockpit crew is from high 
linear energy transfer (LET) radiation, particularly neutrons which are generated due to 
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interactions of cosmic rays [Goldhagen, 2000; IARC, 2000]. In terms of effective dose, the 
radiation doses for airline crew from commercial flights are estimated to be no more than 4–
5 mSv per year [Bottollier-Depois et al., 2000; Verhaegen and Poffijn, 2000] and range 
between 0.2 and 5 mSv [O’Brien and Friedberg, 1994; Oksanen, 1998; Grajewski et al., 
2011]. Cockpit crew members are also exposed to other chemical and physical agents in the 
working environment, such as jet fuel and engine emissions as well as electromagnetic fields 
(EMF) from cockpit instruments and circadian rhythm disruption [Boice et al., 2000].
Reports of elevated risks of cancers of various sites among cockpit crew have raised 
concerns about workplace exposures, particularly cosmic ionizing radiation. Thus far, the 
epidemiological findings on cancer mortality are inconsistent. The most consistent finding 
has been an increased risk of malignant melanoma [Sigurdson and Ron, 2004; Hammer et 
al., 2009]. An increased risk of cancer of the central nervous system (CNS), including brain, 
has also been reported in some but not in all studies [Hammer et al., 2009; Zeeb et al., 
2012]. Elevated risk has been reported for leukemia, especially acute myeloid leukemia, in a 
few studies based on a small number of cases [Sigurdson and Ron, 2004].
In the largest mortality study reported to date, based on the pooled analysis of the data of 
27,797 cockpit crew from nine European countries [Blettner et al., 2003], an increase in 
mortality from malignant melanoma and aircraft accidents, but a decrease in mortality from 
all causes, all cancer, cardiovascular diseases, and lung cancer was observed. Several 
previously published studies have similarly found a pattern of low all-cause [Kaji et al., 
1993; Band et al., 1996; Zeeb et al., 2002, 2010; Paridou et al., 2003; Linnersjö et al., 2011; 
De Stavola et al., 2012], all-cancer [Band et al., 1996; Zeeb et al., 2002, 2010; Paridou et al., 
2003; De Stavola et al., 2012], and cardiovascular disease [Band et al., 1996; Haldorsen et 
al., 2002; Zeeb et al., 2002, 2003; Linnersjö et al., 2011; De Stavola et al., 2012] mortality 
among cockpit crew when comparisons were made with an external general population. A 
high mortality from aircraft accidents has also been observed [Kaji et al., 1993; Band et al., 
1996; Irvine and Davies, 1999; Haldorsen et al., 2002; Zeeb et al., 2002; Linnersjö et al., 
2011; De Stavola et al., 2012], particularly among cockpit crew less than 30 years of age 
[Haldorsen et al., 2002].
An update of the German cohort [Zeeb et al., 2002] has been recently reported by Zeeb et al. 
[2010]. In this extended follow-up of one of the largest individual cohorts of male cockpit 
crew (n=6,017) through 2003 (an average of 22.7 years of follow-up), there was a decrease 
in mortality from all causes and all cancer, but an increase in mortality from cancer of the 
CNS (including brain). However, mortality for radiation-associated cancer (including 
leukemia, esophagus, stomach, large intestine, bladder/urinary tract, and thyroid gland) was 
not increased. A significant trend of decreased mortality from all causes but increased 
mortality from all cancer and CNS cancer across categories of employment duration was 
observed. In another analysis of this German cohort for an average of 23.5 years from 1960 
to 2004 [Hammer et al., 2012], there was a decrease in total mortality (relative risk per 
10mSv: 0.85, 95% CI: 0.79, 0.93) in contrast to a non-significant increase of all cancer 
mortality (relative risk per 10 mSv: 1.05, 95% CI: 0.91, 1.20) with increasing radiation 
doses, which was restricted to non-radiogenic cancers.
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We evaluated the mortality of a cohort of pilots and flight engineers who were employed by 
the Pan American World Airways (Pan Am), a large international airline that closed in 
December 1991. Flight crews of this airline primarily worked on transoceanic and transpolar 
flights and have relatively high exposure to cosmic radiation as well as a long latency 
period. The objectives of this study were to evaluate the: (1) mortality experience of the 
cohort, and (2) relation of duration of employment and the estimated cumulative radiation 
dose with non-chronic lymphocytic leukemia, CNS cancer (including brain), and malignant 
melanoma, the outcomes of a priori interest based on previous studies.
METHODS
Study Cohort and Mortality Follow-Up
The cohort was assembled from the personnel records of Pan Am, which are available for 
employees who stopped working for Pan Am in 1953 or later. Employees who were 
employed as a pilot or/and flight engineer for at least one year before Pan Am closed in 
1991, were U.S. citizens at the time of hire, and who worked at least one day at Pan Am 
after January 1, 1953 were included in the cohort. For 1,007 cohort members, the time 
employed as a pilot or/and flight engineer at other airlines prior to being transferred to Pan 
Am, was counted toward the 1-year minimum requirement. The study was approved by the 
Human Subjects Review Board of the National Institute for Occupational Safety and Health 
(NIOSH) and informed consent was waived for this study.
Vital status of each cohort member through December 31, 2008 was determined using the 
Social Security Administration and Internal Revenue Service records, the National Death 
Index, Pan Am personnel records, and ancestry.com. The causes of death for most deceased 
members were obtained from the National Death Index. For the period prior to 1979, the 
date from which death data are available from the National Death Index, the causes of death 
were obtained from death certificates obtained from state health departments and were 
coded by a nosologist according to the revision of the International Classification of 
Diseases (ICD) in effect at the time of death. Cohort members known to be alive after 
January 1, 1979 (the date from which data are available from the National Death Index) with 
a valid social security number and not identified as deceased or living outside of the U.S. 
after they last worked for Pan Am were assumed to be alive as of December 31, 2008. The 
National Death Index has been shown to provide complete and accurate death information in 
studies with known decedents [Cowper et al., 2002].
Exposure Assessment
Occupational exposures were assessed using two metrics: duration of employment and 
cumulative cosmic radiation dose. The duration of employment was computed from the sum 
of the time employed in jobs involving flying duties.
Details of the assessment of exposure to galactic cosmic radiation have been presented 
previously for studies of former Pan Am flight attendants [Waters et al., 2009; Anderson et 
al., 2011]. Briefly, a database of flight segments was created using information obtained 
from the Official Airline GuideTM [OAG, periodical volumes 1930–1990]. Information on 
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individual flight segments abstracted from the Official Airline Guide included the airline, 
origin and destination of flight, flight year, the number of flights per week for the segment, 
local departure and arrival times, and aircraft type. The company work history records 
indicated a large number of domiciles, and the Official Airline Guide indicated a large 
number of flights flown into those domiciles. Therefore, information was abstracted for nine 
Pan Am domiciles (Hong Kong, Honolulu, London, Los Angeles, Miami, New York, San 
Francisco, Seattle, Washington, DC) and one National Airlines domicile (Miami) for flights 
in the month of April for multiple years (1930, 1935, 1940, 1945, 1950, 1955, 1961, 1965, 
1970, 1980, 1990) representative of flight eras [Waters et al., 2009]. Based on a preliminary 
analysis of electronic company records, these domiciles appeared to be the most common. 
Data for 1961 were used as there were no data available for 1960..
The CARI-6P code [O’Brien et al., 1996] was used to estimate the cosmic ionizing radiation 
effective dose for each flight segment in the database. Required inputs for the CARI-6P 
program (i.e., taxi time, ascent/descent times, and number/duration of cruise altitudes) were 
formulated based on assumptions using a modified algorithm [Grajewski et al., 2002] 
combined with information from former Pan Am pilots [Waters et al., 2009]. Domicile-era-
specific and era-specific dose rates were then calculated using methods described in Waters 
et al. [2009] and Anderson et al. [2011], respectively. These dose rates (μSv/block hour) 
were originally weighted by block time (flight time plus taxi time), number of flights per 
week, and number of flight attendants per flight.
In the current study, the domicile-era-specific and era-specific dose rates were re-calculated 
omitting the weighting for flight attendants as it was assumed that the number of cockpit 
crew on a flight did not vary. As block hours were not available for this cohort, annual flight 
hours, which were reported in individual study subjects’ medical records (and most likely 
estimated by the subjects) were used as a surrogate. Because the quality of flight hour data 
was poor for a significant portion of the cohort, the number of daily flight (block) hours was 
estimated by examining the distribution of annual flight hours reported in the study subjects’ 
medical records. Study subjects were assigned daily effective doses from occupational 
exposure during flights using domicile-era-specific and era-specific dose rates combined 
with the estimated daily flight hours. These daily effective doses were summed over the 
duration of employment to obtain estimates of the cumulative effective dose (hereafter 
referred to as radiation dose).
Statistical Analyses
The mortality experience of the cohort was analyzed using a modified life table analysis 
system, LTAS.NET, developed by NIOSH [Schubauer-Berigan et al., 2011] to calculate 
standardized mortality ratios (SMRs) indirectly standardized to the U.S. population and 
directly standardized rate ratios (SRRs) for internal comparisons. A U.S. general population 
mortality rate file starting on January 1, 1960 with 52 cause-of-death categories was created 
from National Center for Health Statistics mortality data and U.S. census population 
estimates. For each subject, the person-years at risk (PYAR) began after the 1-year 
eligibility period, the date the mortality rate file begins, or, for a cohort member who 
transferred to Pan Am from other airlines, the date of transfer, whichever is later, and 
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continued until the date of death, the date last observed in the U.S., or the study end date 
(December 31, 2008), whichever is earlier. Cohort members who ever lived outside the U.S. 
after they stopped working for Pan Am (n=21, including 12 who are known to have died 
outside of the U.S.) accrued PYAR until the date of their last known address in the U.S. or 
their date of last employment, whichever was later, because the date they emigrated was 
unknown. Some other cohort members only accumulated PYAR until the date last employed 
because they were lost to follow-up (n=217) after they stopped working at Pan Am. In 
addition, individuals who died outside of the U.S. but not known to have emigrated (n=50) 
were considered lost to follow-up in the analysis and accrued PYAR until the day before the 
date of death.
The PYAR were first stratified by gender (male/female), race (White/Other than White), and 
age and calendar year (in 5-year intervals) before being multiplied by the appropriate U.S. 
general population mortality rates to calculate the expected number of deaths for each 
stratum. The resulting expected numbers were summed across strata to obtain cause-specific 
expected deaths. The SMR is the ratio of observed to expected number of deaths. Ninety-
five percent confidence intervals (95% CIs) of the SMRs, assuming that the observed 
number of deaths, D, in the cohort follows a Poisson distribution, were calculated based on 
exact limits when D was 10 or fewer or Byar’s approximation when D was greater than 10 
as described by Breslow and Day [1987].
SRR analyses were conducted to examine exposure-response relation formortality from non-
chronic lymphocytic leukemia, CNS cancer, and malignant melanoma. The mortality 
experience of cohort members in the highest three quartiles for each exposure was compared 
with those in the lowest quartile (referent). Cut points were chosen so that approximately the 
same number of deaths occurred in each exposure quartile, thereby ensuring approximately 
equal precision of rate ratios [Richardson and Loomis, 2004]. Analyses were also lagged for 
2 years for non-chronic lymphocytic leukemia and 10 years for CNS cancer and malignant 
melanoma. These lags were chosen a priori as typical for leukemia and solid tumors 
[UNSCEAR, 2006]. This is equivalent to assuming a minimum latency period before any 
exposure can cause death. In addition, we evaluated the mortality from aircraft accidents by 
duration of employment (<10 vs. ≥10 years). The reported 95% confidence intervals (CIs) 
for the SRRs across the exposure categories were estimated based on the methods described 
by Rothman and Greenland [1998] and Rothman [1986].
Relations between exposure metrics and mortality from non-chronic lymphocytic leukemia, 
CNS cancer, and malignant melanoma were further examined using Cox regression 
modeling. The PHREG Procedure in SAS (version 9.2, SAS Institute, Inc., Cary, NC) was 
used to compute the hazard ratios and 95% CIs based on full risk sets with all possible 
controls. In these analyses, age was the time variable (effectively matching on age). A lag 
for exposure of five (two for leukemia) and 10 years was also evaluated. Tests of 
significance for the hazard ratios, with and without adjustment for the date of birth as a 
potential confounder, were based on the likelihood ratio statistic.
A sensitivity analysis was also conducted to evaluate the effect of underestimation of 
duration of employment for cohort members who were: (1) transferred to two other U.S. 
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airlines when the routes were sold to these airlines in 1986 and 1991 according to the 
personnel records (n=1,246); or (2) laid off when Pan Am closed in 1991 (n=1,504). These 
members were assumed to have worked until an age of 60 years, the mandatory retirement 
age for pilots in the U.S. from 1959–2007 [Aerospace Medical Association, 2004], the date 
of death, the date last observed in the U.S., or study end date, whichever is earlier. Under 
these assumptions, the employment duration was changed for 2,635 (44%) of the total 
cohort (n=5,964) in the analysis. Because the results obtained with or without the change in 
the employment duration for these cohort members were similar, only the latter results are 
presented.
RESULTS
The analytical cohort consists of 5,964 cockpit crew after the exclusion of 23 members who 
died or were lost to follow-up prior to January 1, 1960, the date the mortality rate file begins 
(Table I). The cohort contributed a total of 202,316 PYAR. The cohort is predominantly 
males (97.6% White and 2.3% other than White) and 0.1% White females. Causes of deaths 
were obtained from the National Death Index or death certificates for 97% of the deaths. By 
the end of follow-up on December 31, 2008, there were a total of 2,045 U.S. deaths, which 
include 62 with unknown causes of death (3%) and 3 (0.1%) with an invalid underlying 
cause of death code. The median age at first employment was 28.8 years with the majority 
(62%) first employed before age 30 years. The median time since first employment was 42.2 
years (mean=40.8, range 1.1–75.6); however, 90.5% had 20 or more years since first 
employment. The median duration of employment was 21.6 years (range 1–50.2 years).
Based on the flight hours reported in the medical records, the mean and median annual flight 
hours varied more by era than by domicile, although in both cases, the variation was not 
statistically significant (data not shown). The mean±standard deviation and median annual 
flight hours were 700±200 and 700, respectively, with a range of 0 to 1200 hours. Therefore, 
the median annual flight hours determined for each era was used for the dose estimation. 
The mean annual cosmic radiation dose was 1.4 mSv (median=1.4, range 0.0042–2.8) but 
varied from 0.081 mSv (range 0.00072–0.14) in 1940 to 1.6 mSv (range 0.059–1.8) in 1980. 
The cumulative radiation dose was strongly correlated with the duration of employment 
(Spearman correlation coefficient: 0.90). The mean cumulative radiation dose was 28 mSv 
(median=31; range 0.0047–71).
Table II presents the mortality results based on underlying causes as compared to the U.S. 
general population for the entire cohort. Mortality from all causes (2,045 deaths, SMR 0.58, 
95% CI 0.56, 0.61) and all cancer (645 deaths, SMR 0.69, 95% CI 0.63, 0.74) was 
significantly lower than expected. Mortality was also significantly lower than expected for 
cardiovascular diseases. For the cancers of specific sites (Table II), a non-significant 
elevation of mortality was observed for CNS cancer (32 deaths, SMR 1.39, 95% CI 0.95, 
1.96) and malignant melanoma (23 deaths, SMR 1.48, 95% CI 0.93, 2.21). There was a 
small elevation of mortality from chronic lymphocytic leukemia (9 deaths, SMR 1.14, 95% 
CI 0.52, 2.15) and non-melanoma skin cancer (6 deaths, SMR 1.19, 95% CI 0.44, 2.58). A 
non-significant reduction in mortality was observed for non-chronic lymphocytic leukemia 
(19 deaths, SMR 0.69, 95% CI 0.41, 1.07). Mortality was significantly less than expected for 
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lung cancer (168 deaths, SMR 0.50, 95% CI 0.43, 0.59). Mortality from aircraft accidents 
was significantly elevated (52 deaths, SMR 15.95, 95% CI 11.91, 20.92).
Table III presents the internal SRR analyses stratified by duration of employment for 
mortality from the outcomes of a priori interest. A positive exposure-response relation was 
not observed for mortality from non-chronic lymphocytic leukemia or malignant melanoma 
(with or without a lag). For CNS cancer mortality, the SRR in the highest quartile compared 
to the lowest quartile of cumulative radiation dose was 1.27 (95% CI 0.39, 4.10) without a 
lag and 3.84 (95% CI 1.00, 14.74) with a lag of 10 years. The SRR for aircraft accidents for 
person-time ≥10 (30 deaths) compared to that of <10 years (22 deaths) of employment was 
1.05 (95% CI 0.57, 1.93) (data not shown).
The results of Cox regression analyses for CNS cancer mortality based on the two exposure 
metrics as a continuous variable are shown in Table IV. Mortality from CNS cancer was not 
significantly associated with the duration of employment but was significantly associated 
with the cumulative radiation dose. The hazard ratio per 10 mSv was 2.17, 95% CI 1.06, 
4.81; 2.37, 95% CI 1.09, 5.61; and 2.37, 95% CI 1.01, 6.12 when unlagged and with a lag of 
five and ten years, respectively. No adjustment was made for the date of birth because it did 
not alter the results. Non-chronic lymphocytic leukemia and malignant melanoma mortality 
were not significantly associated with the duration of employment or the cumulative 
radiation dose, with or without a lag (data not shown).
DISCUSSION
In this cohort of 5,964 cockpit crew, we observed a statistically significant lower mortality 
from all causes, all cancer, and cardiovascular diseases when compared with the U.S. 
general population. These results may reflect the high socioeconomic status and healthy 
worker effect of this occupational group highly selected for their health and physical fitness 
[Hammer et al., 2009; Zeeb et al., 2012]. Due to their job requirements, they are also under 
continuing medical surveillance throughout their career to maintain fitness and health in 
order to remain qualified to fly [Sykes et al., 2012]. This may explain the continuing healthy 
worker effect over time. The markedly reduced mortality from lung cancer and 
cardiovascular diseases in this cohort may further suggest the low prevalence of smoking as 
well as other lifestyle-associated cardiovascular disease risk factors among pilots and other 
cockpit crew members as reported by Houston et al. [2011]. However, as in previous studies 
[Kaji et al., 1993; Band et al., 1996; Irvine and Davies, 1999; Haldorsen et al., 2002; Zeeb et 
al., 2002; Blettner et al., 2003; Linnersjö et al., 2011; De Stavola et al., 2012], there is a 
highly elevated mortality from aircraft accidents as compared to the general population. 
Data from other studies suggest that this excess is due in part to occupational aircraft 
accidents [Haldorsen et al., 2002; Linnersjö et al., 2011] and the lack of experience of young 
pilots [Haldorsen et al., 2002]. In this cohort, there was no indication of a significant 
difference in mortality from aircraft accidents for those with ≥10 versus <10 years in 
duration of employment.
The number of leukemia deaths in this cohort is relatively small: 9 from chronic 
lymphocytic leukemia and 19 from non-chronic lymphocytic leukemia. Increased acute 
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myeloid leukemia mortality and incidence have been observed in some studies of cockpit 
crew [Band et al., 1996; Gundestrup and Storm, 1999] with a fivefold increase among 
Danish jet pilots flying more than 5,000 hr compared to the Danish general population 
[Gundestrup and Storm, 1999]. As has been reported in other studies [Zeeb et al., 2002; 
Blettner et al., 2003; Langner et al., 2004], we did not find a significant increase in the 
mortality from leukemia as compared with the general population. Additionally, there was 
no clear association in relation to cumulative cosmic radiation dose for non-chronic 
lymphocytic leukemia which is considered to be induced by ionizing radiation [Sandier and 
Collman, 1987]. Our findings on leukemia mortality could be attributed to the somewhat 
limited statistical power to detect small effects due to the relatively small number of cases 
and low cumulative radiation dose in this occupational group.
An increase in brain cancer mortality was indicated in an earlier study of cockpit crew based 
on small number of cases [Band et al., 1996]. A non-significant elevation in CNS (including 
brain) cancer mortality was reported in the British Airways study [Irvine and Davies, 1999] 
and the pooled European study [Blettner et al., 2003]. CNS (including brain) cancer 
mortality was significantly elevated in the German cockpit crew with a significant trend for 
the duration of employment [Zeeb et al., 2010] and a non-significant trend for radiation dose 
[Hammer et al., 2012]. In this cohort, a non-significant elevation of CNS (including brain) 
cancer mortality based on 32 cases was observed. However, there was a significant increase 
in the mortality with increasing cumulative radiation dose when unlagged or lagged for 5 
and 10 years. The risk factors for CNS cancer and the extent to which specific occupational 
exposures might influence the risk are currently unclear. Evidence for the association with 
ionizing radiation comes mostly from studies of atomic bomb survivors [Preston et al., 
2002] and patients undergoing high therapeutic radiation doses [UNSCEAR, 2006]. There is 
also limited human evidence that EMF, a known exposure in the cockpit, causes CNS cancer 
[Cogliano et al., 2011].
An increased risk of malignant melanoma has been reported in several incidence studies 
[Gundestrup and Storm, 1999; Haldorsen et al., 2000; Rafnsson et al., 2000; Pukkala et al., 
2002] and in some [Irvine and Davies, 1999; Blettner et al., 2003] but not all [Zeeb et al., 
2010] mortality studies. We found an elevated but non-significant increase in mortality from 
malignant melanoma in this cohort. There was no evidence for an association with duration 
of employment or cumulative radiation dose. It is difficult, however, to evaluate risk of 
melanoma in mortality studies due to the high survival rate of this outcome. Exposure to 
ultraviolet radiation which is a risk factor for melanoma is considered minimal during 
commercial flights due to the protective materials in aircraft windows [Diffey and Roscoe, 
1990]. Although a positive dose-response has been shown in relation to radiation dose 
among Nordic pilots, it has been suggested that this may be attributed to ultraviolet radiation 
from excessive sun exposure [Pukkala et al., 2002]. In a study among Icelandic flight crew 
and a subset of age and gender-matched general population, Rafnsson et al. [2003] found 
that sun exposure factors did not solely account for the difference in melanoma risk. 
However, in another study evaluating melanoma incidence in air traffic control officers and 
cockpit crew with respect to occupational exposures and lifestyle factors, the excess risk was 
found to reflect sun-related behavior rather than cosmic radiation exposure [dos Santos Silva 
et al., 2013].
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The estimated cumulative (lifetime) radiation dose of this cohort is below 100 mSv. The 
mean cumulative dose is similar to that reported for the Pan Am flight attendants [Anderson 
et al., 2011], although the distribution for the cockpit crew is somewhat narrower and less 
skewed. In addition, the mean annual dose in this cohort is within the range previously 
estimated for cockpit crew [O’Brien and Friedberg, 1994; Oksanen, 1998]. On the other 
hand, there are several sources of uncertainty in the dose estimates for individual pilots, 
including the lack of individual flight histories, that is, specific routes and block hours 
flown, aircraft type (long-/short haul), etc. The use of average dose rates based on eras and 
domiciles along with using median annual flight hours could result in significant 
underestimation or overestimation for individual cohort members [Anderson et al., 2011]. 
Also, potential exposure to radiation from solar particle events was not accounted for in the 
dose estimates. In addition, there could be an underestimation of the duration of employment 
and cumulative dose because of reliance on past personnel records and the lack of data on 
work at other airlines. The results of the sensitivity analysis suggest that the study findings 
by duration of employment were unaltered by the underestimation of the duration of 
employment for some cohort members. The impact of the underestimation of cumulative 
dose for some cohort members on the study findings by cumulative dose are less clear 
because the mean annual cosmic radiation dose from occupational exposure during flights 
increased, in general, over time. However, cumulative radiation dose and employment 
duration at Pan Am and National Airlines were highly correlated, which suggests that the 
impact may have been minimal.
This study has several strengths compared to previous studies of cockpit crew. Our cohort 
has one of the longest average duration of employment and time since first employment to 
date. However, despite having one of the largest number of observed deaths to date, the 
numbers of many specific cancer sites are still small with limited power to detect small 
effects and to evaluate dose-response in relation to duration of employment and cumulative 
radiation dose. There are a number of study limitations, including the use of mortality rather 
than incidence data for the evaluation of cancer risk. In addition, we did not evaluate the 
effect of other occupational exposures or circadian rhythm disruption from crossing multiple 
time zones. Several studies have found a non-significant increase in prostate cancer 
mortality or incidence [Band et al., 1996; Irvine and Davies, 1999; Rafnsson et al., 2000; 
Pukkala et al., 2002]. In agreement with other studies [Blettner et al., 2003; Zeeb et al., 
2010], we did not observe an excess in mortality from prostate cancer, a hormone-related 
cancer which may be associated with circadian rhythm disruption [Hammer et al., 2012]. 
However, cumulative time zones crossed but not work at night as a metric of circadian 
rhythm disruption was shown to be strongly correlated with the estimated cumulative 
cosmic radiation dose in the Pan Am flight attendant study [Pinkerton et al., 2012]. Thus, it 
is difficult to disentangle the effect of circadian rhythm disruption from that of radiation, 
although this may be possible in some cohorts depending on the types of routes flown, 
especially if data on the specific flights flown by each cohort member are available 
[Grajewski et al., 2002].
In conclusion, results of this study of a cohort of cockpit crew with one of the largest 
number of observed deaths to date are consistent with those reported in other studies. There 
is a significant decrease in mortality from all causes, all cancer, and cardiovascular diseases, 
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but an elevated mortality from aircraft accidents as compared to the U.S. general population. 
Mortality was elevated for CNS cancer and malignant melanoma but not for non-chronic 
lymphocytic leukemia. In internal analyses, the estimated cumulative radiation dose was 
associated with mortality from CNS cancer in both unlagged and lagged analyses but not 
with mortality from malignant melanoma. These findings suggest a need for further studies 
to clarify the risk of CNS and other radiation-associated cancers in relation to cosmic 
radiation and other workplace exposures.
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TABLE I
Characteristics of the Study Cohort
Total
Excluded from analysisa 23
Number of workers 5,964
Person-years 202,316
Race/sex
 Male
  White 5,820 (97.6%)
  Other than White 138 (2.3%)
 Female
  White 6 (0.1%)
  Other than White 0
Vital status (as of 12/31/2008)
 Alive 3,631 (60.9%)
 Emigratedb 21 (0.4%)
 Lost to follow-up 217 (3.6%)
 Foreign deathc 50 (0.8%)
 U.S. death 2,045 (34.3%)
Year of birth
 Median (range) 1934 (1896–1967)
Year of first employmentd
 Median (range) 1965 (1929–1990)
Age at first employmentd (years)
 <20 8 (0.1%)
 20–<25 868 (14.6%)
 25–<30 2,807 (47.1%)
 30–<35 1,630 (27.3%)
 35+ 651 (10.9)
Time since first employmentd (years)
 <10 83 (1.4%)
 10–<20 486 (8.2%)
 20+ 5,395 (90.5)
Duration of employmentd (years)
 <5 1,197 (20.1%)
 5–<10 371 (6.2%)
 10–<15 442 (7.4%)
 15–<20 572 (9.6%)
 20+ 3,382 (56.7%)
Estimated cumulative radiation dose (mSv)
 <3 547 (9.2%)
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Total
 3–<10 850 (14.3%)
 10–<20 602 (10.1%)
 20–<30 857 (14.4%)
 30–<40 1,329 (22.3%)
 40–<50 1,250 (21.0%)
 50+ 529 (8.9%)
a
Died or were lost to follow-up prior to January 1,1960, the date the mortality rate file begin.
b
Includes 12 cohort members known to have died outside of the U.S.
c
In the analysis, these cohort members were considered lost to follow-up and accrued PYAR until the day before the date of death.
d
Based on employment as a pilot or/and flight engineer at Pan Am or other airlines excluding leave>30 days.
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TABLE II
SMRs for the Overall Cohort (1960–2008, U.S. Referent Rates)
Underlying cause of death OBS SMR 95% CI
All deathsa 2,045 0.58 0.56, 0.61
All cancers 645 0.69 0.63, 0.74
Buccal/pharynx 22 1.15 0.72, 1.74
Digestive cancers
 Esophagus 16 0.56 0.32, 0.92
 Stomach 10 0.39 0.19, 0.72
 Large intestine 62 0.80 0.62, 1.03
 Rectum 13 0.79 0.42, 1.36
 Biliary tree/liver 16 0.64 0.37, 1.04
 Pancreas 36 0.76 0.53, 1.05
All respiratory cancers
 Larynx 5 0.47 0.15, 1.09
 Bronchus, tree, and lung 168 0.50 0.43, 0.59
Breast cancer 2b 1.71 0.21, 6.18
Male genital cancers
 Prostate 77 0.90 0.71, 1.12
 Testis/other male genital organs 1 0.52 0.01, 2.91
Urinary cancers
 Kidney 13 0.53 0.28, 0.90
 Bladder/other urinary tract 16 0.60 0.34, 0.97
Lymphocytic and hematopoietic cancers
 Hodgkin disease 2 0.56 0.07, 2.03
 Non-Hodgkin’s lymphoma 27 0.75 0.49, 1.09
 Chronic lymphocytic leukemia 9 1.14 0.52, 2.15
 Non-chronic lymphocytic leukemia 19 0.69 0.41, 1.07
All other and unspecified cancer
 Eye 2 4.13 0.50, 14.92
 Bone 1 0.56 0.01, 3.10
 Malignant melanoma 23 1.48 0.93, 2.21
 Non-melanoma skin 6 1.19 0.44, 2.58
 Central nervous system (including brain) 32 1.39 0.95, 1.96
 Thyroid gland/other endocrine 2 0.77 0.09, 2.79
Benign neoplasms 15 0.97 0.55, 1.61
Diabetes mellitus 28 0.34 0.23, 0.49
Cardiovascular diseases
 Cerebrovascular disease 108 0.61 0.50, 0.74
 Rheumatic heart disease 3 0.30 0.06, 0.88
 All ischemic heart disease 231 0.49 0.43, 0.55
 Acute myocardial infarction 160 0.37 0.31, 0.43
Am J Ind Med. Author manuscript; available in PMC 2015 July 22.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Yong et al. Page 16
Underlying cause of death OBS SMR 95% CI
 All other cardiovascular disease 118 0.47 0.39, 0.56
Non-malignant respiratory disease 96 0.41 0.33, 0.50
Liver cirrhosis 54 0.81 0.61, 1.05
Motor vehicle accidents 26 0.50 0.33, 0.73
Aircraft accidents 52 15.95 11.91, 20.92
Suicides 51 0.93 0.69, 1.22
Homicide/accidental death 3 0.21 0.04, 0.61
All other external causes 45 0.54 0.40, 0.73
All unknown and other causes of deathsc 295 0.79 0.71, 0.89
ICD, International Classification of Diseases; OBS, observed; SMR, standardized mortality ratio; CI, confidence interval.
a
Excludes deaths that occurred outside of the U.S.
b
Male breast cancer.
c
Includes unknown causes of death (n=62) and others with an invalid underlying cause of death code (n =3).
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TABLE IV
Cox Regression Results for Cancer of the Central Nervous System (Including Brain) Mortality (n=32)*
Exposure Hazard ratio 95% CI P-valuea
Duration of employment per 10 years
 Unlagged 1.45 0.96–2.33 0.08
 5-year lag 1.50 0.96–2.50 0.08
 10-year lag 1.47 0.90–2.57 0.13
Cumulative radiation dose per 10 mSv
 Unlagged 2.17 1.06–4.81 0.03
 5-year lag 2.37 1.09–5.61 0.03
 10-year lag 2.37 1.01–6.12 0.05
CI, confidence interval.
*Age was the time variable and risk sets were constructed with all possible controls.
a
Based on the likelihood ratio statistic.
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